MARKET

SCNI

SCNI

Scinai Immunotherapeutics Ltd.
NASDAQ
0.5090
+0.0241
+4.96%
After Hours: 0.5090 0 0.00% 16:10 11/11 EST
OPEN
0.4987
PREV CLOSE
0.4850
HIGH
0.5475
LOW
0.4634
VOLUME
231.98K
TURNOVER
--
52 WEEK HIGH
13.00
52 WEEK LOW
0.3901
MARKET CAP
1.34M
P/E (TTM)
0.0055
1D
5D
1M
3M
1Y
5Y
1D
Scinai Immunotherapeutics Reports 167% Revenue Growth as CDMO Expands
TipRanks · 2d ago
Weekly Report: what happened at SCNI last week (1102-1106)?
Weekly Report · 2d ago
Scinai Immunotherapeutics reports nine-month results
Seeking Alpha · 6d ago
Scinai Immunotherapeutics Expands U.S. CDMO Agreement To $5.1M In Committed Base Services
Benzinga · 6d ago
Scinai Reports Significant Revenue Growth in First Nine Months of 2026 as CDMO Business Expands
PR Newswire · 6d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 11/03 21:05
Weekly Report: what happened at SCNI last week (1026-1030)?
Weekly Report · 11/02 09:06
Scinai registers to sell 7.59M ADRs for holders
TipRanks · 10/28 20:12
More
About SCNI
Scinai Immunotherapeutics Ltd (formerly known as BiondVax Pharmaceuticals Ltd) is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing biological products for the prevention and treatment of autoimmune and infectious diseases and other inflammatory and immunological conditions. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as psoriasis and asthma. Scinai Immunotherapeutics Ltd's NanoAbs are based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company provides contract development and manufacturing organization (CDMO) services, including analytical method development, process development, and clinical cGMP manufacturing services, to biotechnology companies. Scinai Immunotherapeutics Ltd operates in the State of Israel.

Webull offers Scinai Immunotherapeutics Ltd - ADR stock information, including NASDAQ: SCNI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNI stock methods without spending real money on the virtual paper trading platform.